Information in the news releases is current on the date of the announcement, but is subject to change without prior notice. News release search
People also ask
Why is Eisai stock dropping?
Is Eisai a good company?
How big is Eisai Pharmaceuticals?
Who is the owner of Eisai Pharma?
Eisai's media center is where you'll find breaking news, press releases, as well as blogs and articles about the company, our people, and our innovations.
Welcome to the Eisai Official Corporate Website Latest News Page.
Search through Eisai's media center, where you'll find breaking news, blogs, and articles about the company, our people, and our innovations.
/news/index.html · May 27, 2024. “LEQEMBI®” (Lecanemab) Approved for the Treatment of Alzheimer's Disease in South Korea · May 23, 2024. EISAI SHOWCASES ONCOLOGY ...
Eisai's Alzheimer's drug Leqembi gets green light in Japan, shares surge. In a significant development for Eisai Co (OTC:ESAIY)., the Japanese health ministry ...
7 days ago · Eisai's news release EISAI SHOWCASES ONCOLOGY PORTFOLIO AND PIPELINE AT ASCO 2024 is posted.
Feb 5, 2024 · Japan's Eisai aims to roll out its groundbreaking Alzheimer's drug Leqembi to 1500 people in China later this year, but expects growth to ...
News for Eisai Co. Ltd. Seeking Alpha 5d. Eisai projects major growth for Alzheimer's therapy Leqembi. Seeking Alpha 5d. Eisai GAAP EPS of ¥147.86, ...
Get Eisai Co Ltd (4523.T-JP:Tokyo Stock Exchange) real-time stock quotes, news, price and financial information from CNBC.